Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures

Background: To determine whether previously reported reductions in hypoglycemia associated with insulin glargine 300 U/mL (Gla-300) compared with insulin glargine 100 U/mL (Gla-100) are impacted by patient risk category in type 2 diabetes (T2D), clinical performance measures based on the Healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingvay, Ildiko, Chao, Jason, Dalal, Mehul R., Meneghini, Luigi F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444481/
https://www.ncbi.nlm.nih.gov/pubmed/28467113
http://dx.doi.org/10.1089/dia.2016.0454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444481/
https://www.ncbi.nlm.nih.gov/pubmed/28467113
http://dx.doi.org/10.1089/dia.2016.0454

Ejemplares similares